A Mobile Phone Enabled Diagnostic Platform for Monitoring Drug Compliance

Amit Srivastava of Children's Hospital, Boston in the U.S., along with colleagues at MIT, will develop a novel drug compliance platform combining the use of mobile phones for a simple diagnostic test, with economic incentives. The device will include a platform that measures drug metabolites in bodily fluids to generate a readout. Test results submitted on time will result in immediate economic rewards, such as additional cell phone minutes.